Rubicon Founders’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154M Buy
5,971,079
+22,415
+0.4% +$519K 78.21% 1
2026
Q1
$122M Buy
5,948,664
+175,142
+3% +$3.95M 88.92% 1
2025
Q4
$137M Hold
5,773,522
83.22% 1
2025
Q3
$144M Hold
5,773,522
72.08% 1
2025
Q2
$133M Hold
5,773,522
62.42% 1
2025
Q1
$130M Hold
5,773,522
79.71% 1
2024
Q4
$113M Hold
5,773,522
100% 1
2024
Q3
$105M Hold
5,773,522
100% 1
2024
Q2
$100M Buy
5,773,522
+562,386
+11% +$9.96M 100% 1
2024
Q1
$102M Hold
5,211,136
100% 1
2023
Q4
$120M Buy
+5,211,136
New +$117M 100% 1

Other funds holding PRVA

Rubicon Founders's PRVA Position: Q2 2026 in Review

Rubicon Founders increased its Privia Health (PRVA) stake by 0.38% in Q2 2026, buying an estimated $519K and bringing the position to 5,971,079 shares worth $154M. The position accounts for 78.21% of the portfolio, ranked #1.

Rubicon Founders first reported a position in PRVA in Q4 2023 and has held it in 11 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Rubicon Founders held 5,971,079 shares of Privia Health worth $154M as of Q2 2026.
  • Rubicon Founders bought 22,415 Privia Health shares in Q2 2026, an estimated $519K.
  • Privia Health made up 78.21% of Rubicon Founders's portfolio in Q2 2026, its #1 holding.
  • Rubicon Founders first reported a position in Privia Health in Q4 2023 and has held it in 11 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Rubicon Founders's 13F filing for Q2 2026, filed 14 Aug 2026.